血友病基因治疗的最新进展:预测前景
Nikita Chernyi1, Darina Gavrilova2, Mane Saruhanyan1
1Laboratory of Molecular Virology, First Moscow State Medical University (Sechenov University), Moscow 119435, Russia.
Biomolecules
|July 27, 2024
概括
基因疗法为血友病A和B提供了一个有希望的替代方案,有可能克服目前昂贵的输液治疗的局限性. 这种方法旨在长期表达第八或第九因子,降低出血风险.
科学领域:
- 遗传学和分子生物学
- 血液学 血液学 血液学
- 基因治疗 基因治疗
背景情况:
- 血友病A和B分别是由F8 (第八因子) 或F9 (第九因子) 基因突变引起的X链接遗传疾病.
- 严重的血友病导致<1%的因子活性,导致自发或创伤性出血,并发症和死亡.
- 目前的治疗包括使用凝血因子或单克隆抗体的终身,昂贵的替代疗法.
研究的目的:
- 审查血友病A和B的传统和现代治疗方法.
- 专注于基因疗法作为一种潜在的变革性治疗方式.
- 总结最近的技术进步和正在进行的基因疗法.
主要方法:
- 关于传统血友病治疗的文献评论.
- 对血友病A和B的基因疗法方法的批判性审查.
- 对最近的技术进步和新兴基因疗法的分析.
主要成果:
- 基因疗法为长期内源性表达第八或第九因子提供了潜在的一次性体内载体输送.
- 基因疗法可以克服传统治疗的局限性,包括成本和对抗体药物的免疫反应.
- 几种基因疗法正在研发中,这表明该领域的快速进步.
结论:
- 基因疗法被认为是对血友病最有前途的未来治疗方法.
- 它有潜力通过解决当前疗法的挑战来显著改善患者的治疗结果.
- 基因疗法的持续研究和开发对于实现这一潜力至关重要.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
CRISPR
50.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.2K
What is Genetic Engineering?
74.0K
Overview
74.0K
Recombinant DNA
93.7K
Overview
93.7K


